MedPath

Ampicillin sodium

Ampicillin for Injection, USP

Approved
Approval ID

34e95c91-3767-493c-8716-38e61e7c6674

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 10, 2023

Manufacturers
FDA

Armas Pharmaceuticals Inc.

DUNS: 098405973

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ampicillin Sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72485-422
Application NumberANDA201025
Product Classification
M
Marketing Category
C73584
G
Generic Name
Ampicillin Sodium
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateNovember 10, 2023
FDA Product Classification

INGREDIENTS (1)

AMPICILLIN SODIUMActive
Quantity: 2 g in 1 1
Code: JFN36L5S8K
Classification: ACTIM

Ampicillin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72485-421
Application NumberANDA201025
Product Classification
M
Marketing Category
C73584
G
Generic Name
Ampicillin
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateNovember 10, 2023
FDA Product Classification

INGREDIENTS (1)

AMPICILLIN SODIUMActive
Quantity: 1 g in 1 1
Code: JFN36L5S8K
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ampicillin sodium - FDA Drug Approval Details